JNGLX
Price
$69.24
Change
+$0.01 (+0.01%)
Updated
Jan 22 closing price
Net Assets
4.78B
PHSYX
Price
$64.49
Change
-$0.15 (-0.23%)
Updated
Jan 22 closing price
Net Assets
1.6B
Ad is loading...

JNGLX vs PHSYX

Header iconJNGLX vs PHSYX Comparison
Open Charts JNGLX vs PHSYXBanner chart's image
Janus Henderson Global Life Sciences D
Price$69.24
Change+$0.01 (+0.01%)
VolumeN/A
Net Assets4.78B
Putnam Global Health Care Y
Price$64.49
Change-$0.15 (-0.23%)
VolumeN/A
Net Assets1.6B
JNGLX vs PHSYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. PHSYX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and PHSYX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.78B vs. PHSYX (1.6B). PHSYX pays higher dividends than JNGLX: PHSYX (0.33) vs JNGLX (0.12). JNGLX was incepted earlier than PHSYX: JNGLX (26 years) vs PHSYX (25 years). PHSYX is a more actively managed with annual turnover of: 41.00 vs. JNGLX (34.00). PHSYX has a lower initial minimum investment than JNGLX: PHSYX (0) vs JNGLX (2500). JNGLX (-1.91) and PHSYX (-1.98) have marching annual gain over last year. JNGLX return over 5 years is better than : 17.44 vs. PHSYX (8.74).
JNGLXPHSYXJNGLX / PHSYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years25 years-
Gain YTD1.9893.05265%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.78B1.6B298%
Annual Yield % from dividends0.120.3336%
Returns for 1 year-1.91-1.9896%
Returns for 3 years12.921.55833%
Returns for 5 years17.448.74199%
Returns for 10 years31.26-6.92-452%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCRX7.620.01
+0.13%
BioCryst Pharmaceuticals
NFE15.59-0.03
-0.19%
New Fortress Energy
LOAN5.66-0.09
-1.57%
Manhattan Bridge Capital
ANIK16.22-0.28
-1.70%
Anika Therapeutics
SMFG14.51-0.47
-3.14%
Sumitomo Mitsui Financial Group